NCT03072992View on ClinicalTrials.gov

"Curcumin in Combination With Chemotherapy in Advanced Breast Cancer"

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

November 20, 2018

Study Completion Date

June 30, 2019

Conditions
Advanced Breast CancerMetastatic Breast Cancer
Interventions
DRUG

Curcumin

Curcumin (CUC-01), 300mg i.v. , once weekly for 12 weeks.

DRUG

Paclitaxel

Paclitaxel (colorless solution) 80 mg /m2 BS, i.v., once weekly for 12 weeks.

DRUG

Placebo

Placebo i.v. solution, once weekly for 12 weeks

Trial Locations (1)

0052

National Center of Oncology, Yerevan

All Listed Sponsors
collaborator

BRIU GmbH

UNKNOWN

lead

National Center of Oncology, Armenia

OTHER

NCT03072992 - "Curcumin in Combination With Chemotherapy in Advanced Breast Cancer" | Biotech Hunter | Biotech Hunter